您的购物车当前为空
HSD17B13-IN-17 (compound 9) 作为一种对 hydroxysteroid 17?-dehydrogenase 13 (HSD17B13) 高效的抑制剂,显示出在雌二醇和白三烯 B3 的IC50值分别小于 0.1 μM 和小于 1 μM。它在非酒精性脂肪性肝病 (NAFLD),包括 NASH(非酒精性脂肪性肝炎)的研究中扮演着重要角色。

HSD17B13-IN-17 (compound 9) 作为一种对 hydroxysteroid 17?-dehydrogenase 13 (HSD17B13) 高效的抑制剂,显示出在雌二醇和白三烯 B3 的IC50值分别小于 0.1 μM 和小于 1 μM。它在非酒精性脂肪性肝病 (NAFLD),包括 NASH(非酒精性脂肪性肝炎)的研究中扮演着重要角色。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 10-14周 | |
| 50 mg | 待询 | 10-14周 |
HSD17B13-IN-17 相关产品
| 产品描述 | HSD17B13-IN-17 (compound 9) serves as a potent inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13). It demonstrates inhibitory efficacy with IC50 values of <0.1 μM for estradiol and <1 μM for Leukotriene B3 as substrates. This compound is significant in the management of nonalcoholic fatty liver diseases (NAFLDs), including nonalcoholic steatohepatitis (NASH) [1]. |
| 分子量 | 418.87 |
| 分子式 | C20H16ClFN2O3S |
| CAS No. | 2758802-10-5 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
评论内容